Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
2,498,847
-
Share change
-
-75,676
-
Total reported value
-
$13,394,000
-
Price per share
-
$5.36
-
Number of holders
-
6
-
Value change
-
-$417,986
-
Number of buys
-
2
-
Number of sells
-
4
Institutional Holders of INTEC PHARMA LTD JERUSALEM - SHS as of Q4 2015
As of 31 Dec 2015,
INTEC PHARMA LTD JERUSALEM - SHS was held by
6 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,498,847 shares.
The largest 6 holders included
Cormorant Asset Management, LLC, SABBY MANAGEMENT, LLC, Opaleye Management Inc., PERCEPTIVE ADVISORS LLC, DAFNA Capital Management LLC, and UBS Group AG.
This page lists
6
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.